Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$136.09
+1.3%
$132.94
$99.71
$141.23
$233.80B0.736.15 million shs5.75 million shs
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
$79.20
+2.8%
$78.78
$70.22
$109.00
$74.63B0.876,213 shs53,644 shs
Novartis AG stock logo
NVS
Novartis
$121.08
+0.9%
$114.16
$96.06
$121.24
$253.51B0.591.58 million shs1.28 million shs
Roche Holding AG stock logo
RHHBY
Roche
$40.76
-0.4%
$39.99
$33.76
$44.31
$260.92B0.461.24 million shs782,798 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+1.26%+2.12%+1.80%+3.33%+30.97%
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
+2.78%+1.03%-0.44%-0.33%-19.59%
Novartis AG stock logo
NVS
Novartis
+0.65%+2.99%+4.68%+10.58%+13.73%
Roche Holding AG stock logo
RHHBY
Roche
-0.37%+1.80%+1.02%-0.78%+17.57%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.8809 of 5 stars
2.43.04.24.52.92.52.5
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
1.1364 of 5 stars
0.03.01.70.01.90.01.3
Novartis AG stock logo
NVS
Novartis
1.6479 of 5 stars
1.03.02.50.02.80.01.9
Roche Holding AG stock logo
RHHBY
Roche
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.76
Moderate Buy$142.614.79% Upside
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
4.00
Strong BuyN/AN/A
Novartis AG stock logo
NVS
Novartis
2.00
Hold$123.381.90% Upside
Roche Holding AG stock logo
RHHBY
Roche
2.57
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest CSLLY, RHHBY, NVS, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/16/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
6/16/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$143.00
4/28/2025
Roche Holding AG stock logo
RHHBY
Roche
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
4/28/2025
Roche Holding AG stock logo
RHHBY
Roche
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$133.00 ➝ $145.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$132.00 ➝ $142.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$140.00 ➝ $145.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$117.00 ➝ $127.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$136.00 ➝ $147.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$158.00 ➝ $159.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $145.00
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.64$6.67 per share20.41$27.62 per share4.93
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
$14.80B5.18$4.09 per share19.37$20.07 per share3.95
Novartis AG stock logo
NVS
Novartis
$50.32B5.08$10.79 per share11.22$21.59 per share5.61
Roche Holding AG stock logo
RHHBY
Roche
$68.73B3.78$3.28 per share12.41$6.44 per share6.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.7117.6523.752.5531.89%19.01%10.82%7/17/2025 (Estimated)
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
$2.64BN/A0.0019.361.88N/AN/AN/A8/19/2025 (Estimated)
Novartis AG stock logo
NVS
Novartis
$11.94B$6.4018.9213.741.7324.70%39.44%16.43%7/17/2025 (Estimated)
Roche Holding AG stock logo
RHHBY
Roche
$9.40BN/A0.0013.592.61N/AN/AN/A7/24/2025 (Estimated)

Latest CSLLY, RHHBY, NVS, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/17/2025Q2 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.25N/AN/AN/A$11.01 billionN/A
7/17/2025Q2 2025
Novartis AG stock logo
NVS
Novartis
$2.37N/AN/AN/A$13.94 billionN/A
4/29/2025Q1 2025
Novartis AG stock logo
NVS
Novartis
$2.12$2.28+$0.16$1.83$12.92 billion$13.23 billion
4/16/2025Q1 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07$1.09+$0.02$0.76$10.38 billion$10.36 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.73%N/A30.61%54 Years
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
$1.201.52%N/AN/AN/A
Novartis AG stock logo
NVS
Novartis
$2.602.15%N/A40.63%N/A
Roche Holding AG stock logo
RHHBY
Roche
$0.872.13%N/AN/AN/A

Latest CSLLY, RHHBY, NVS, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/13/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.73%7/15/20257/15/20258/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.26
1.78
1.27
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
0.45
1.86
0.85
Novartis AG stock logo
NVS
Novartis
0.56
0.79
0.61
Roche Holding AG stock logo
RHHBY
Roche
0.85
1.48
1.20

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
0.03%
Novartis AG stock logo
NVS
Novartis
13.12%
Roche Holding AG stock logo
RHHBY
Roche
N/A

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
N/A
Novartis AG stock logo
NVS
Novartis
0.01%
Roche Holding AG stock logo
RHHBY
Roche
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
CSL Limited Sponsored ADR stock logo
CSLLY
CSL
32,698968.42 millionN/ANot Optionable
Novartis AG stock logo
NVS
Novartis
75,8832.11 billion2.11 billionOptionable
Roche Holding AG stock logo
RHHBY
Roche
103,2496.38 billionN/ANot Optionable

Recent News About These Companies

Changes to the Roche Enlarged Corporate Executive Committee
RHHBY Roche Holding AG - Seeking Alpha
RHHBY - Roche Holding AG ADR Key Metrics - Morningstar
RHHBY - Roche Holding AG ADR Dividends - Morningstar
UBS Keeps Their Buy Rating on Roche Holding AG (RHHVF)
Roche And Prothena: Why Moving On Makes Sense
Genentech Provides Update on Phase III Verona Study

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$136.09 +1.71 (+1.27%)
As of 06/30/2025 03:58 PM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

CSL stock logo

CSL OTCMKTS:CSLLY

$79.20 +2.14 (+2.78%)
As of 06/30/2025 03:54 PM Eastern

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Novartis stock logo

Novartis NYSE:NVS

$121.08 +1.07 (+0.89%)
As of 06/30/2025 03:58 PM Eastern

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Roche stock logo

Roche OTCMKTS:RHHBY

$40.76 -0.15 (-0.37%)
As of 06/30/2025 04:00 PM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.